To validate the clinical significance of CD44 and GABRP in patients with pancreatic cancer, a Spearman’s correlation analysis was conducted based on the starBase V3.0 website to analyze co-expression of CD44 and GABRP in various cancers (Fig. 4A). The gene discussed is GABRP; the disease is cancer.